Last reviewed · How we verify
SmartPill®
At a glance
| Generic name | SmartPill® |
|---|---|
| Sponsor | Acerta Pharma BV |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Gastrointestinal pH and Motility After the Consumption of Milk (NA)
- A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants (PHASE1)
- Evaluation of Gastrointestinal Motility With SmartPill
- Postoperative Ileus: Duration and Severity Assessment With the SmartPill® (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SmartPill® CI brief — competitive landscape report
- SmartPill® updates RSS · CI watch RSS
- Acerta Pharma BV portfolio CI